[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[$abp](/topic/$abp)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$abp/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$abp/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% +2%  
**6 Months**: XX% -XX%  
**1-Year High**: XXX% on 2024-11-17  
**1-Year Low**: XX% on 2024-11-21  

**Most Supportive Themes**
- **Potential for 180-day extension and Nasdaq compliance:** (45%) Community anticipates a 6-month extension from Nasdaq, which could lead to significant price movement.
- **Positive Preclinical Data and Partnerships:** (35%) Recent preclinical data for ABP-102/CT-P72 (HER2 x CD3) with Celltrion and partnerships are viewed positively.
- **Undervaluation and Long-Term Upside:** (15%) Many posts highlight the stock's current undervaluation, with some analysts predicting substantial long-term gains.
  
**Most Critical Themes**
- **Nasdaq Non-Compliance and Dilution Concerns:** (5%)  The stock's non-compliance with Nasdaq's minimum bid price and concerns about potential dilution are causing some caution.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %   |
| ------- | -------- | -   | ------- | -   | -------- | -   |
| X       | XXXXX    | XX% | XXXXX   | XX% | XXXXX    | XX% |
| YouTube | X        | X%  | X       | X%  | X        | X%  |
|         |          |     |         |     |          |     |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XXXXX    | XX% |